Mid-Year Report

NOSSAMAN LLP for MERCK & COMPANY INC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceutical for Children Act (S.1082 - Prescription Drug User Fee Amendments of 2007, H.R. 2900 - Food and Drug Administration Amendments Act of 2007). Support efforts to promote public/private partnerships for health technology assessment (no specific legislation). Oppose efforts to permit Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Secretary in any Rx drug importation legislation (no specific bill).

LobbyistCovered position, as disclosed
TIMOTHY W JENKINS N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1082 (110th), H.R. 2900 (110th)

Medicare/Medicaid MMM

Support efforts to ensure appropriate access to vaccines under Medicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R.4- Medicare Prescription Drug Price Negotiation Act of 2007, and S.250 - Medicare Enhancements for Needed Drugs Act of 2007).

LobbyistCovered position, as disclosed
TIMOTHY W JENKINS N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 250 (110th), H.R. 4 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.